Bayer AG: Turnaround and Legal Relief Pave the Way for New Growth

After a landmark ruling by the US Supreme Court in the glyphosate dispute, Bayer AG experiences a significant legal relief. At the same time, the management is decisively advancing the strategic and financial restructuring of the company. For investors, the operational potential of the core businesses is now increasingly in focus.   The Diversified Life Science Business Model in Focus Bayer AG positions itself as a globally operating life science company whose core competencies are focused on the areas of health and agriculture. The operational...